Pasar al contenido principal

CITOESQUELETO E INFLAMACION EN INFECCIONES VIRALES: NUEVAS OPCIONES EN LA BUSQUEDA DE ANTIVIRALES DE AMPLIO ESPECTRO

PID2021-123399OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

  • López-Ayllón, Blanca D.
  • Marín, Silvia
  • Farinas Fernández, Marcos
  • García-García, Tránsito
  • Fernández-Rodríguez, Raúl
  • Lucas-Rius, Ana de
  • Redondo, Natalia
  • Mendoza-García, Laura
  • Foguet, Carles
  • Grigas, Juozas
  • Calvet, Alba
  • Villalba, José Manuel
  • Rodríguez Gómez, María Josefa
  • Megías, Diego
  • Mandracchia, Biagio
  • Lozano, Juan José
  • Calvo, Cristina
  • Thomson, Timothy M.
  • Garrido, Juan J.
  • Cascante, Marta
  • Montoya, María
Antiviral signaling, immune response and cell metabolism in human body are dysregulated by SARS-CoV-2, the causative agent of the COVID-19. Here, we show that SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 induce a significant mitochondrial and metabolic reprogramming in A549 lung epithelial cells. While all four ORFs caused mitochondrial fragmentation and altered mitochondrial function, only ORF3a and ORF9c induced a marked structural alteration in mitochondrial cristae. ORF9b, ORF9c and ORF10 induced largely overlapping transcriptomes. In contrast, ORF3a induced a distinct transcriptome, including the downregulation of numerous genes for proteins with critical mitochondrial functions and morphology. Genome-Scale Metabolic Models predicted common and private metabolic flux reprogramming, notably a depressed amino acid metabolism, and an enhanced metabolism of specific lipids distinctly induced by ORF3a. These findings reveal metabolic dependencies and vulnerabilities prompted by SARS-CoV-2 accessory proteins that may be exploited to identify new targets for intervention., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089), Spanish Ministry of Science project (PID2021-123399OB-I00), the Agency for Management of University and Research Grants from Generalitat de Catalunya-AGAUR (2020PANDE00048 and 2021SGR00350) and ICREA foundation (ICREA-Academia-2021 to MC) of Generalitat de Catalunya, and an AESi grant of the Instituto de Salud Carlos III (PI20CIII-00014). TGG is recipient of a Ramón y Cajal contract funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2

  • López-Ayllón, Blanca D.
  • Mendoza-García, Laura
  • Lucas-Rius, Ana de
  • García-García, Tránsito
  • Fernández-Rodríguez, Raúl
  • Romero-Guillén, Antonio
  • Serrat, Judit
  • Zúñiga Lucas, Sonia
  • Redondo, Natalia
  • Siles Lucas, Mar
  • Garrido, Juan J.
  • Montoya, María
From the early days of the COVID-19 pandemic, an excessive release of proinflammatory cytokines, such as IL6, was detected in serum from patients. As a consequence, several anti-inflammatory drugs, such as Dexamethasone (a strong corticoid), were used to counteract such cytokine storm occurring during severe disease. By contrast, pro-inflammatory interleukin 11 (IL11), a member of the IL6 family, was detected in respiratory tissues from infected patients and in experimental epithelial cellular models. In this work, human A549 lung epithelial cells were individually transduced with SARS-CoV-2 open reading frames (ORFs), resulting in a IL11 increase, which was significantly decreased after Dexamethasone treatment. The use of this cellular platform allowed us to screen for new possible anti-inflammatory compounds from Fasciola hepatica. Our results highlighted the ability of FhNEJ (Fasciola hepatica newly excysted juvenile flukes) somatic extract to decrease IL11 levels in ORF-transduced cells. These results emphasized the role of IL11 in lung epithelial inflammation, making it a potential target for future treatments of lung inflammation which occurs in COVID-19, and validate the use of these ORF-expressing cells as a cellular platform to test anti-inflammatory compounds for COVID-19 disease., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science project (PID2021-123399OB-I00). TGG is recipient of a Ramón y Cajal contract funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR. This research work was also supported in part by the European Commission— Next Generation EU fund (Regulation EU 2020/2094), awarded to M.S.-L. through CSIC’s Global Health Platform (PTI Salud Global). M.S.-L. acknowledges the financial support of the Spanish Ministry of Science and Innovation (Project PID2019-108782RB365 C22), and the Project “CLU-2019-05—IRNASA/CSIC Unit of Excellence”, funded by the Junta de Castilla y León and co-financed by the European Union (ERDF “Europe drives our growth”). J.S. acknowledges the support of the Junta de Castilla y León for her Predoctoral contract., No